ELVN
Enliven Therapeutics, Inc.
Set alert
44.25 USD -0.83 -1.84%
44.09 Day range 45.87
14.79 52-week range 62.32
- YTD
- +187.34%
- 1 year
- +84.61%
- Open
- 44.92
- Prev close
- 45.08
- Mkt cap
- 3.24B
- Vol
- 1.24M
- Avg vol
- 1.35M
- EPS
- -1.67
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 44.09
- High
- 45.87
- Forward P/E
- -19.10
- Beta
- 0.34
- Short ratio
- 5.98
- Inst. own
- 115.69%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2026
- 50-d avg
- 49.00
- 200-d avg
- 42.64
- 1y target
- 74.42
Period ending Jun 30, 2026 · select a line to chart its history
Income statement
| 37.21M | |
| 29.00M | |
| 8.21M | |
| -37.21M | |
| -32.48M | |
| -32.48M | |
| -32.48M | |
| -32.48M | |
| -0.49 | |
| -0.49 | |
| -0.49 | |
| -32.48M | |
| -32.48M | |
| 66.17M | |
| 66.17M |
Balance sheet
| 135.50M | |
| 135.50M | |
| 759.65M | |
| 759.65M | |
| 907.34M | |
| 1.64M | |
| 910.22M | |
| 14.16M | |
| 15.07M | |
| -403.28M | |
| -1.91M | |
| 895.15M | |
| 895.15M | |
| 2.88M | |
| 913.00K | |
| 371.00K |
Cash flow
| 133.00K | |
| 463.42M | |
| 3.32M | |
| -99.00K | |
| 463.42M | |
| -441.57M | |
| -441.47M | |
| -18.53M | |
| 13.91M |